# APBA Kısa Özet

A retrospective observational study of 392 critically ill COPD exacerbation patients developed and internally validated a multivariable prognostic model using age, male sex, urea, albumin, CRP, and Charlson Comorbidity Index. The model demonstrated excellent discriminatory performance (AUC 0.899) and significantly outperformed APACHE II (AUC 0.813). Calibration was good (Hosmer-Lemeshow p=0.066), and internal validation via 1000 bootstrap resamples confirmed stability. The authors conclude that while the model shows promise, external validation and comparison with established COPD-specific models are required before clinical implementation.

# Çalışma neyi araştırdı?

This retrospective observational study aimed to develop and internally validate a multivariable prognostic model for predicting in-hospital mortality in critically ill patients with acute exacerbation of COPD. The research team also sought to compare the newly developed model's performance against the established APACHE II scoring system. The study population consisted of 392 adult patients admitted to the ICU with acute exacerbation of COPD between January 2022 and December 2025. The investigators analyzed demographic characteristics, laboratory findings, arterial blood gas parameters, Charlson Comorbidity Index scores, and APACHE II scores to identify independent predictors of mortality.

# Yöntem

The study employed a retrospective observational design involving 392 adult patients with acute exacerbation of COPD admitted to the ICU. Data collection encompassed demographic characteristics, laboratory findings, arterial blood gas parameters, Charlson Comorbidity Index, and APACHE II scores. Multivariable logistic regression analysis was performed to identify independent predictors of in-hospital mortality. The researchers developed a prediction model based on the significant variables identified. Discriminatory performance was assessed using the area under the receiver operating characteristic curve (AUC). Calibration was evaluated using the Hosmer-Lemeshow test. Internal validation was conducted using 1,000 bootstrap resamples to assess model stability and overfitting. The model's performance was then compared with APACHE II using the DeLong test for statistical significance.

# Temel bulgular

The multivariable logistic regression analysis identified six independent predictors of in-hospital mortality: age, male sex, urea, albumin, C-reactive protein (CRP), and Charlson Comorbidity Index. The final prediction model demonstrated excellent discriminatory performance with an AUC of 0.899 (95% CI: 0.865-0.927). This discriminatory ability significantly outperformed APACHE II, which had an AUC of 0.813 (95% CI: 0.771-0.851); the difference was statistically significant (DeLong p = 0.0014). Calibration assessment using the Hosmer-Lemeshow test yielded a p-value of 0.066, indicating good calibration. Internal validation via 1,000 bootstrap resamples confirmed the model's stability and robustness.

# Bulgular ne anlama geliyor?

The developed six-variable prognostic model shows promise as a potentially simpler and more disease-specific alternative to APACHE II for predicting in-hospital mortality in critically ill COPD exacerbation patients. With an AUC of 0.899, the model demonstrates excellent discriminatory performance. The statistically significant improvement over APACHE II (AUC 0.813) suggests that this new model may better capture the specific prognostic factors relevant to this patient population. However, the researchers emphasize that these findings are based on internal validation only, and the model's performance in external, diverse populations remains to be determined.

# Klinik önem

While the model demonstrates excellent discriminatory performance and significantly outperforms APACHE II, the study's authors and this summary stress that the model is not yet ready for routine clinical implementation. The requirement for external validation in diverse patient populations is paramount before any clinical decision-making can be based on this tool. Additionally, direct comparison with established COPD-specific prognostic models is needed to determine its relative value. Clinicians should continue to rely on established scoring systems and clinical judgment until further validation data are available.

# Sınırlılıklar

This study has several important limitations that must be considered. First, the study performed internal validation only; external validation in independent cohorts was not conducted. Second, the study design was single-center, which may limit the generalizability of the findings to other healthcare settings. Third, the retrospective observational design carries inherent risks of selection bias and unmeasured confounding. Fourth, the study did not perform a direct comparison with established COPD-specific prognostic models, limiting the interpretation of the model's relative performance. Finally, the study period spans 2022-2025, potentially including recent practice changes that could affect the model's generalizability.